Shorter- versus Longer-duration Dual Antiplatelet Therapy in Patients with Diabetes Mellitus Undergoing Drug-eluting Stents Implantation: A Meta-analysis of Randomized Controlled Trials

BACKGROUND: Patients with diabetes mellitus (DM) have a higher risk of thromboembolic events; however, the optimal duration of dual antiplatelet therapy (DAPT) remains unclear. The goal of this study was to assess the efficacy and safety of various DAPT durations in patients with DM undergoing drug-...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, He, Li, Ya, Chen, Yu, Fu, Guo-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146796/
https://www.ncbi.nlm.nih.gov/pubmed/27901002
http://dx.doi.org/10.4103/0366-6999.194663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5146796/
https://www.ncbi.nlm.nih.gov/pubmed/27901002
http://dx.doi.org/10.4103/0366-6999.194663

Ejemplares similares